N J L M

 
Subscribe Via RSS
  • Home
  • About
    Salient Features Bibliographic Information Abstracting and Indexing Specialties Covered Publisher Journal Policy
  • Issues
    Current Issue Online Ahead of Print Archive Forthcoming issue
  • Editorial
    Editorial Statements Editorial-PeerReview Process Editorial Board Publication Ethics & Malpractice Join us
  • Authors
    Submit an Article Manuscript Instructions Manuscript Assistance Publication Charges Paid Services Early Online Publication Service
  • Reviewers
    Apply as Reviewer Reviewers Acknowledgment
  • Search
    Simple Search Advanced Search
  • Member
    Register Login
  • Contact
  • Subscription
Case report
Year : 2025 Month : October Volume : 14 Issue : 4 Page : PC08 - PC11 Full Version

Gastric Adenocarcinoma With Enteroblastic Differentiation: A Clear Cell Conundrum


Bharathi Prasanna, Saranya, Rajesh Nataraj, Gomathi, K Swaminathan
1. Postgraduate, Institute of Pathology, Madras Medical College, Chennai, Tamil Nadu, India. 2. Assistant Professor, Institute of Pathology, Madras Medical College, Chennai, Tamil Nadu, India. 3. Senior Assistant Professor, Institute of Pathology, Madras Medical College, Chennai, Tamil Nadu, India. 4. Professor, Institute of Pathology, Madras Medical College, Chennai, Tamil Nadu, India. 5. Professor, Institute of Pathology, Madras Medical College, Chennai, Tamil Nadu, India.
 
Correspondence Address :
Bharathi Prasanna,
3rd Floor, Institute of Pathology, Madras Medical College, Park Town, Chennai,
Tamil Nadu, India.
E-mail: prasannaraj1019@gmail.com
 
ABSTRACT
: Gastric Adenocarcinoma with Enteroblastic Differentiation (GAED) is an aggressive and rare subtype of Gastric Carcinoma (GC). The authors report a case of 65-year-old male presented with complaints of upper Gastrointestinal tract (GI) bleeding for two months. Endoscopy revealed an ulceroproliferative growth in the incisura and distal body of stomach. Small biopsy was suggestive of adenocarcinoma. Patient underwent D1 subtotal gastrectomy. Gross specimen had an ulcerative growth in the lesser curvature. Histopathology showed malignant neoplasm consisting of tubules lined by cuboidal to columnar cells with clear cytoplasm resembling primitive foetal gut epithelium. Periodic Acid-Schiff (PAS) staining highlighted the glycogen rich clear cytoplasm. Oncofoetal Immunohistochemical (IHC) markers such as Glypican-3 (GPC3) and Spalt-like transcription factor (SALL-4) were positive supporting enteroblastic differentiation. Tumour penetrated the subserosal tissue and showed lymph node metastasis. Compared to conventional GCs, GAED has aggressive behavior and poor prognosis with tumour showing early deep tumour invasion, lymph node and distant metastasis. Serum tumour marker such as Alpha-fetoprotein (AFP) can be elevated aiding in diagnosis and follow up. Further prognostic markers such as Human Epidermal Growth Factor Receptor 2 (HER2/neu) was done and was negative and tumour protein p53 (p53) showed mutant type staining underscoring GAEDs aggressive nature. Recognition of this histologic subtype is crucial, to differentiate it from other AFP producing and clear cell tumours such as hepatoid gastric adenocarcinoma, metastatic clear cell renal cell carcinoma, yolk sac tumour-like adenocarcinoma, well differentiated tubular or papillary adenocarcinoma with clear cell features, and in case of patient presenting with early liver metastasis from primary hepatocellular carcinoma. The present case highlighted the importance of considering GAED as a differential on encountering clear cells in a gastric cancer which also resembled foetal intestinal epithelium. Histochemical staining such as PAS and IHC staining like AFP for antigen markers like, GPC3, SALL-4, Hepatocyte Paraffin 1 (HepPar1) and sometimes cytokeratin can help with the diagnosis and to exclude other clear cell tumours. HER2/neu was negative and p53 IHC showed mutant-type expression. Early diagnosis of this rare aggressive subtype is essential to guide further follow up, improving patient outcome and further understanding of its clinicopathologic spectrum.
Keywords : Carcinoma stomach, Foetal gut epithelium, Alpha-fetoprotein, Glypican 3
DOI and Others : DOI: 10.7860/NJLM/2025/81670.2942 Date of Submission: Jul 18, 2025 Date of Peer Review: Aug 09, 2025 Date of Acceptance: Aug 13, 2025 Date of Publishing: Oct 01, 2025 AUTHOR DECLARATION: • Financial or Other Competing Interests: None • Was informed consent obtained from the subjects involved in the study? Yes • For any images presented appropriate consent has been obtained from the subjects. Yes PLAGIARISM CHECKING METHODS: • Plagiarism X-checker: Jul 19, 2025 • Manual Googling: Aug 05, 2025 • iThenticate Software: Aug 12, 2025 (6%) ETYMOLOGY: Author Origin EMENDATIONS: 5
 
TABLES AND FIGURES
 
  • In This Article

    • Abstract
    • Material and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgement
    • References
  • Article Utilities

    • Readers Comments
    • Article in PDF
    • Citation Manager
    • How to Cite
    • Article Statistics
    • Print this Article
    • Send to a Friend
  • Go To Issues

    • Current Issue
    • Past Issues
  • Search Articles

    • Simple Search
    • Advance Search
  • Authors Facilities

    • Extensive Author Support
    • Submit Manuscript
    • ONLINE First Facility
    • NJLM Pre Publishing
  • Quick Links

    • REVIEWER
    • ACCESS STATISTICS
  • Users

    • Register
    • Log in
  • Pages

    • About
    • Issues
    • Editorials
    • Authors
    • Reviewers
    • Search
    • Contacts
  • Issues Archives

  • Affiliated Websites

    • JCDR Prepublishing
    • Neonatal Database Home
    • JCDR Neonatal Database download center